Advertisement
Forex-Nachrichten
European Stocks Close Higher On Bargain Hunting
European stocks closed higher on Monday, due largely to bargain hunting at several counters after last week's selloff. Data showing an a significant improvement in German business confidence in December helped a bit in lifting sentiment.
RTTNews |
vor 863 Tagen
Canadian Market Moderately Lower At Noon In Cautious Trade
After opening slightly up and advancing a bit, the Canadian market slipped into negative territory Monday morning, and is moderately lower around noon, weighed down by losses in healthcare, technology and materials sectors.
RTTNews
|
vor 863 Tagen
U.S. Housing Market Index Unexpectedly Drops For 12th Straight Month In December
Homebuilder confidence in the U.S. has unexpectedly seen a continued deterioration in the month of December, according to a report released by the National Association of Home Builders on Monday. The report showed the NAHB/Wells Fargo Housing Market Index fell to 31 in December from 33 in November. The decreased surprised economists, who had expected the index to rise to 36.
RTTNews
|
vor 863 Tagen
Abbott Says FDA Approves Eterna Spinal Cord Stimulation System To Treat Chronic Pain
Abbott (ABT) announced Monday the U.S. Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable spinal cord stimulator currently available on the market for the treatment of chronic pain.
RTTNews
|
vor 863 Tagen
Inflation, Interest Rates Sway Currency Trajectory
The updates on inflation and the response of central banks tasked with taming it, shaped currency market sentiment for much of the week ended December 16.
RTTNews
|
vor 863 Tagen
Terex Board Of Directors Authorizes New Share Repurchase Program Of Up To $150 Mln
Terex Corp. (TEX) announced Monday that its Board of Directors authorized a new share repurchase program of up to $150 million.
RTTNews
|
vor 863 Tagen
Atara Biotherapeutics Says Carol Gallagher To Replace Ron Renaud As Chair Of The Board Of Directors
Atara Biotherapeutics, Inc. (ATRA) announced Monday that Carol Gallagher will assume the role of Chair of the Board of Directors, replacing Ron Renaud, who is stepping down to focus on his new position as Managing Director at Bain Capital Life Sciences.
RTTNews
|
vor 863 Tagen
more news
Bay Street Looks Headed For Higher Open
Firm commodity prices and modestly higher Canadian and U.S. futures point to a positive start on Bay Street on Monday.
RTTNews
|
vor 863 Tagen
Twitter Users Vote In Favor Of Elon Musk Resigning As Boss
Will Elon Musk, current Twitter chief following his $44 billion acquisition of the social media platform, resign from the role as suggested by his millions of Twitter followers in a poll? It was on Sunday that Musk, who also heads Tesla and Space X, initiated a poll, asking his some 122 million followers whether he should step down as head of Twitter. He also said then that he would abide.
RTTNews
|
vor 863 Tagen
Equifax Floats Offer To Acquire Brazil's Boa Vista Serviços In $583 Mln Deal
Data, analytics, and technology company Equifax, Inc. (EFX) announced Monday it has made an offer to the Boa Vista Serviços' Board of Directors to acquire all outstanding shares of Boa Vista Serviços, the second largest consumer credit bureau in Brazil, for R$8.00 per share, implying an estimated total enterprise value of R$3.103 billion, or $583 million.
RTTNews
|
vor 863 Tagen
ADC Therapeutics Appoints Jose Carmona To Succeed Jenn Creel As CFO
ADC Therapeutics SA (ADCT) announced Monday the appointment of Jose "Pepe" Carmona as Chief Financial Officer (CFO), effective December 19, 2022. He will serve on the Company's executive leadership team and succeeds Jenn Creel, who is leaving to pursue other opportunities.
RTTNews
|
vor 863 Tagen
World Market Trends
Here is a snapshot of the world markets at this hour across stocks, currencies, bonds, commodities and cryptocurrencies.
RTTNews
|
vor 863 Tagen
Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD
Atara Biotherapeutics, Inc. (ATRA) and French healthcare company Pierre Fabre announced Monday that the European Commission (EC) has granted marketing authorization for Ebvallo (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.
RTTNews
|
vor 863 Tagen
Stay up to date!
Add Nachrichten to your browser
Add To Chrome
